ES2118283T3 - Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos. - Google Patents

Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos.

Info

Publication number
ES2118283T3
ES2118283T3 ES94106320T ES94106320T ES2118283T3 ES 2118283 T3 ES2118283 T3 ES 2118283T3 ES 94106320 T ES94106320 T ES 94106320T ES 94106320 T ES94106320 T ES 94106320T ES 2118283 T3 ES2118283 T3 ES 2118283T3
Authority
ES
Spain
Prior art keywords
derivatives
tiofenil
alcanocarboxilicos
benzofuranil
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94106320T
Other languages
English (en)
Inventor
Rudiger Dr Fischer
Gabriele Dr Braunlich
Klaus-Helmut Dr Mohrs
Rudolf Dr Hanko
John-Edward D Butler-Ransohoff
Mazen Dr Es-Sayed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2118283T3 publication Critical patent/ES2118283T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LOS DERIVADOS DEL ACIDO BENZOFURANIL OCARBOXILICO DE LA FORMULA (I) DONDE R1, R2, R3, T, V, Y W SON COMO ESTAN DEFINIDOS EN LA REIVINDICACION 1 SE PREPARAN POR CICLIZACION DE ACETOFENONES HIDROXI Y COMPONENTES RELACIONADOS O POR LA REACCION WITTIG DE ALDEHIDOS BENZOFURANIL. LOS COMPONENTES PUEDEN SER USADOS PARA PREPARAR MEDICAMENTOS QUE MUESTRAN ACTIVIDAD ANTI INFLAMATORIA.
ES94106320T 1993-05-06 1994-04-22 Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos. Expired - Lifetime ES2118283T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939309324A GB9309324D0 (en) 1993-05-06 1993-05-06 Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives

Publications (1)

Publication Number Publication Date
ES2118283T3 true ES2118283T3 (es) 1998-09-16

Family

ID=10735023

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94106320T Expired - Lifetime ES2118283T3 (es) 1993-05-06 1994-04-22 Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos.

Country Status (21)

Country Link
US (1) US5504213A (es)
EP (1) EP0623607B1 (es)
JP (1) JP3452088B2 (es)
CN (1) CN1097749A (es)
AT (1) ATE168373T1 (es)
AU (1) AU678814B2 (es)
CA (1) CA2122788A1 (es)
CZ (1) CZ112994A3 (es)
DE (1) DE69411625T2 (es)
DK (1) DK0623607T3 (es)
ES (1) ES2118283T3 (es)
FI (1) FI942049A (es)
GB (1) GB9309324D0 (es)
GR (1) GR3027787T3 (es)
HU (1) HUT67847A (es)
IL (1) IL109526A0 (es)
NO (1) NO941662L (es)
NZ (1) NZ260445A (es)
RU (1) RU2125564C1 (es)
SK (1) SK53194A3 (es)
ZA (1) ZA943100B (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
HRP950288A2 (en) * 1994-05-31 1997-08-31 Bayer Ag Oxalylamino-benzofuran- and benzothienyl-derivatives
GB9410877D0 (en) * 1994-05-31 1994-07-20 Bayer Ag Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
DE69507197T2 (de) * 1994-05-31 1999-05-27 Bayer Ag, 51373 Leverkusen Aminobenzofuryl- und -thienylderivate
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US6043264A (en) * 1995-01-06 2000-03-28 Toray Industries, Inc. Benzene-condensed heterocyclic derivatives and their uses
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
RU2162467C2 (ru) * 1996-05-20 2001-01-27 Дарвин Дискавери Лимитед Карбоксамиды бензофурана и их фармацевтическая композиция
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
DE19642451A1 (de) * 1996-10-15 1998-04-16 Merck Patent Gmbh Aminothiophencarbonsäureamide
DE19706396A1 (de) * 1996-12-09 1998-06-10 Bayer Ag Verfahren zur Herstellung von 3-(l-Hydroxiphenyl-l-alkoximinomethyl)dioxazinen
GB2350109A (en) 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
DE60043318D1 (de) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
CA2436130A1 (en) 2001-01-29 2002-08-08 3-Dimensional Pharmaceuticals, Inc. Substituted indoles and their use as integrin antagonists
US6872730B2 (en) * 2001-04-27 2005-03-29 3-Dimensional Pharmaceuticals, Inc. Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
US20040146561A1 (en) 2001-05-23 2004-07-29 Naoki Sakurai Compositions for promoting healing of bone fracture
CN1537018A (zh) 2001-05-23 2004-10-13 田边制药株式会社 一种用于软骨疾病再生治疗的组合物
RU2350609C2 (ru) * 2002-02-22 2009-03-27 БАЙЕР ХелсКер ЛЛСи Производные бензофурана и бензотиофена, применяемые при лечении гиперпролиферативных заболеваний
US7144885B2 (en) * 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR20050115331A (ko) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 불임증 포스포디에스터라제의 억제제
JP2005008631A (ja) * 2003-05-29 2005-01-13 New Industry Research Organization ベンゾフラン化合物、およびそれを含有してなる医薬組成物
US7638540B2 (en) 2003-05-29 2009-12-29 The New Industry Research Organization Benzofuran compound and medicinal composition containing the same
JP2007504228A (ja) * 2003-09-02 2007-03-01 メルク　エンド　カムパニー　インコーポレーテッド 高眼圧症を治療するための眼組成物
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
RS52307B (en) * 2006-06-27 2012-12-31 Takeda Pharmaceutical Company Limited CONDENSED CYCLIC UNITS
US20100125073A1 (en) * 2006-09-01 2010-05-20 Olaf Weber Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
US9890132B2 (en) 2013-08-25 2018-02-13 Council Of Scientific & Industrial Research Process for the preparation of anti-inflammatory aroylbenzofuran compounds
CA2940625C (en) * 2014-02-25 2021-10-12 Ecolab Usa Inc. De-odorizing sanitary cleaner
CN105254611B (zh) * 2015-11-09 2017-10-31 江西仁明医药化工有限公司 苯并噻吩‑2‑羧酸的制备方法
CN107827849B (zh) * 2017-11-14 2020-06-02 沈阳药科大学 6-[2-羟基-3-(烷胺基)丙氧基]苯并呋喃类化合物及其应用
CN107857748B (zh) * 2017-11-14 2020-06-02 沈阳药科大学 5-[2-羟基-3-(烷胺基)丙氧基]苯并呋喃类化合物及其应用
CN107935972B (zh) * 2017-11-14 2020-06-02 沈阳药科大学 5-[2-羟基-3-(异丙胺基)丙氧基]苯并呋喃类衍生物及其应用
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN110938035B (zh) * 2019-10-28 2022-07-01 广西师范大学 9-苯磺酸-10-咪蒽腙及其合成方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019955A1 (en) * 1979-05-16 1980-12-10 Shell Internationale Researchmaatschappij B.V. Benzofurancarboxylic acid derivatives, their preparation and their inclusion in lipogenesis inhibiting compositions
EP0146243A1 (en) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
US4663347A (en) * 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
US4482772A (en) * 1983-11-03 1984-11-13 Mobil Oil Corporation Multistage process for converting oxygenates to hydrocarbons

Also Published As

Publication number Publication date
NO941662L (no) 1994-11-07
CA2122788A1 (en) 1994-11-07
DE69411625D1 (de) 1998-08-20
GR3027787T3 (en) 1998-11-30
RU94015838A (ru) 1997-02-20
FI942049A (fi) 1994-11-07
EP0623607A1 (en) 1994-11-09
DK0623607T3 (da) 1999-04-19
EP0623607B1 (en) 1998-07-15
FI942049A0 (fi) 1994-05-04
HU9401415D0 (en) 1994-08-29
JP3452088B2 (ja) 2003-09-29
NO941662D0 (no) 1994-05-05
ZA943100B (en) 1995-01-09
CZ112994A3 (en) 1994-11-16
AU678814B2 (en) 1997-06-12
GB9309324D0 (en) 1993-06-16
CN1097749A (zh) 1995-01-25
RU2125564C1 (ru) 1999-01-27
US5504213A (en) 1996-04-02
SK53194A3 (en) 1995-02-08
DE69411625T2 (de) 1998-11-05
IL109526A0 (en) 1994-08-26
AU6055894A (en) 1994-11-10
NZ260445A (en) 1995-08-28
HUT67847A (en) 1995-05-29
ATE168373T1 (de) 1998-08-15
JPH06329652A (ja) 1994-11-29

Similar Documents

Publication Publication Date Title
ES2118283T3 (es) Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos.
DK506587D0 (da) Imidderivater
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
ES2105362T3 (es) Nuevos derivados de acidos quinolon- y naftiridoncarboxilicos.
ATE294593T1 (de) Inclusion-komplex von beta-cyclodextrin mit diclofenac
ATE191317T1 (de) Verwendung von beta-aminopropionsäure-derivaten als fungizide
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
ES2109530T3 (es) Derivados de acidos fenil-ciclohexano-carboxilicos heterotriciclicamente sustituidos.
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
DE69533573D1 (de) Anxiolytischer wirkstoff
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
AU6797590A (en) Improvements in or relating to organic compounds
ES2195309T3 (es) Derivados de tetrahidrofurano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 623607

Country of ref document: ES